Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ali Afshar-Oromieh

Showing results (1-10 of 122) with videos related to

Pageof 13
Sort By:
Der Orthopade|December 20, 2021
[Radiosynoviorthesis of the thumb's carpometacarpal joint]Clemens Mingels, Keivan Daneshvar, Ali Afshar-Oromieh
Clinical Nuclear Medicine|July 9, 2019
68Ga-Prostate-Specific Membrane Antigen Uptake in a Malignant Pleural Effusion From Metastatic Prostate Cancer After PleurodesisChristos Sachpekidis, Ian Alberts, Axel Rominger, et al.
PET Clinics|September 17, 2018
Radionuclide Therapy for Bone Metastases: Utility of Scintigraphy and PET Imaging for Treatment PlanningHojjat Ahmadzadehfar, Markus Essler, Kambiz Rahbar, et al.
Plos One|July 19, 2022
A randomised, prospective and head-to-head comparison of [68Ga]Ga-PSMA-11 and [18F]PSMA-1007 for the detection of recurrent prostate cancer in PSMA-ligand PET/CT-Protocol design and rationaleIan Alberts, Lukas Bütikofer, Axel Rominger, et al.
Nuklearmedizin. Nuclear Medicine|May 15, 2019
PSMA-ligand PET allows a more accurate therapeutic response evaluation of bone metastases in prostate cancer compared to computed tomographyViktor Fech, Ian Alberts, Axel Rominger, et al.
Molecular Imaging|June 7, 2018
PSMA Theranostics: Current Status and Future DirectionsKambiz Rahbar, Ali Afshar-Oromieh, Hossein Jadvar, et al.
PET Clinics|May 31, 2021
Prostate Cancer Theranostics: PSMA Targeted TherapyRobert Seifert, Ian L Alberts, Ali Afshar-Oromieh, et al.
Cancers|December 24, 2021
Radiolabeled PSMA InhibitorsOliver C Neels, Klaus Kopka, Christos Liolios, et al.
PET Clinics|May 31, 2021
Prostate Cancer Theranostics: From Target Description to ImagingIan L Alberts, Robert Seifert, Kambiz Rahbar, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 28, 2022
Assessment of malignancy and PSMA expression of uncertain bone foci in [<sup>18</sup>F]PSMA-1007 PET/CT for prostate cancer-a single-centre experience of PET-guided biopsiesBernd Vollnberg, Ian Alberts, Vera Genitsch, et al.
Pageof 13

Showing results (1-10 of 122) with videos related to

Sort By:
Pageof 13
Der Orthopade|December 20, 2021
[Radiosynoviorthesis of the thumb's carpometacarpal joint]Clemens Mingels, Keivan Daneshvar, Ali Afshar-Oromieh
Clinical Nuclear Medicine|July 9, 2019
68Ga-Prostate-Specific Membrane Antigen Uptake in a Malignant Pleural Effusion From Metastatic Prostate Cancer After PleurodesisChristos Sachpekidis, Ian Alberts, Axel Rominger, et al.
PET Clinics|September 17, 2018
Radionuclide Therapy for Bone Metastases: Utility of Scintigraphy and PET Imaging for Treatment PlanningHojjat Ahmadzadehfar, Markus Essler, Kambiz Rahbar, et al.
Plos One|July 19, 2022
A randomised, prospective and head-to-head comparison of [68Ga]Ga-PSMA-11 and [18F]PSMA-1007 for the detection of recurrent prostate cancer in PSMA-ligand PET/CT-Protocol design and rationaleIan Alberts, Lukas Bütikofer, Axel Rominger, et al.
Nuklearmedizin. Nuclear Medicine|May 15, 2019
PSMA-ligand PET allows a more accurate therapeutic response evaluation of bone metastases in prostate cancer compared to computed tomographyViktor Fech, Ian Alberts, Axel Rominger, et al.
Molecular Imaging|June 7, 2018
PSMA Theranostics: Current Status and Future DirectionsKambiz Rahbar, Ali Afshar-Oromieh, Hossein Jadvar, et al.
PET Clinics|May 31, 2021
Prostate Cancer Theranostics: PSMA Targeted TherapyRobert Seifert, Ian L Alberts, Ali Afshar-Oromieh, et al.
Cancers|December 24, 2021
Radiolabeled PSMA InhibitorsOliver C Neels, Klaus Kopka, Christos Liolios, et al.
PET Clinics|May 31, 2021
Prostate Cancer Theranostics: From Target Description to ImagingIan L Alberts, Robert Seifert, Kambiz Rahbar, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 28, 2022
Assessment of malignancy and PSMA expression of uncertain bone foci in [<sup>18</sup>F]PSMA-1007 PET/CT for prostate cancer-a single-centre experience of PET-guided biopsiesBernd Vollnberg, Ian Alberts, Vera Genitsch, et al.
Pageof 13